Pages that link to "Q48502840"
Jump to navigation
Jump to search
The following pages link to Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography (Q48502840):
Displaying 50 items.
- Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms (Q27023109) (← links)
- (R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus (Q30993837) (← links)
- Central Neurotoxicity in Cancer Chemotherapy: Pharmacogenetic inSights (Q33857581) (← links)
- Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat data (Q34100185) (← links)
- Regional P-glycoprotein activity and inhibition at the human blood-brain barrier as imaged by positron emission tomography (Q34125735) (← links)
- Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters (Q34204238) (← links)
- Age-related changes in the hepatic pharmacology and toxicology of paracetamol (Q35101500) (← links)
- Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease (Q35184647) (← links)
- Reproducibility of quantitative (R)-[11C]verapamil studies (Q35742284) (← links)
- Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes (Q35768413) (← links)
- The blood-brain barrier: geriatric relevance of a critical brain-body interface. (Q36342064) (← links)
- P-glycoprotein function at the blood-brain barrier: effects of age and gender (Q36382013) (← links)
- Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs (Q36442886) (← links)
- Advances in PET imaging of P-glycoprotein function at the blood-brain barrier (Q36638627) (← links)
- Membrane transporter proteins: a challenge for CNS drug development. (Q36659167) (← links)
- The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers (Q36729143) (← links)
- PET tracer technology for monitoring focal epilepsies (Q36759514) (← links)
- Clinical pharmacokinetics of antiretroviral drugs in older persons (Q36905884) (← links)
- Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET. (Q36947632) (← links)
- Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PET. (Q36949854) (← links)
- PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo (Q36953090) (← links)
- The clinical implications of ageing for rational drug therapy (Q37052681) (← links)
- The blood-brain barrier in migraine treatment (Q37252452) (← links)
- Clinical pharmacology in old persons (Q37288132) (← links)
- Drug interactions at the blood-brain barrier: fact or fantasy? (Q37362486) (← links)
- Variability in response to medicines in older people: phenotypic and genotypic factors. (Q37395760) (← links)
- Pharmacokinetics and drug metabolism in the elderly (Q37514319) (← links)
- ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs (Q37575649) (← links)
- ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer (Q37595188) (← links)
- The Immunomodulatory Effects of Plant Extracts and Plant Secondary Metabolites on Chronic Neuroinflammation and Cognitive Aging: A Mechanistic and Empirical Review (Q37692206) (← links)
- Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry (Q37791156) (← links)
- Molecular Mechanisms of Drug Transporter Regulation (Q37811969) (← links)
- A tipping point in drug dosing in late-life schizophrenia (Q37843821) (← links)
- Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier. (Q38166961) (← links)
- Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier. (Q38351240) (← links)
- Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations. (Q38747735) (← links)
- Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11 C]verapamil in elderly vs. young subjects. (Q38841102) (← links)
- Pharmacokinetic and pharmacodynamic alterations in older people with dementia (Q39275819) (← links)
- Efflux proteins at the blood-brain barrier: review and bioinformatics analysis (Q39290800) (← links)
- Cluster headache and intracranial aneurysm (Q42413674) (← links)
- Decreased blood-brain barrier P-glycoprotein function with aging (Q45860417) (← links)
- Image-derived input functions for PET brain studies (Q46230609) (← links)
- Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil (Q48176609) (← links)
- 1α,25-Dihydroxyvitamin D3 reduces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer's disease (Q48778991) (← links)
- Cerebrospinal Fluid Abacavir Concentrations in HIV-positive Patients Following Once-daily Administration. (Q49997422) (← links)
- Blood-brain barrier P-glycoprotein function in Alzheimer's disease (Q50778486) (← links)
- Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET (Q57792155) (← links)
- Serum Concentrations and Elimination Rates of Direct-Acting Oral Anticoagulants (DOACs) in Older Hip Fracture Patients Hospitalized for Surgery: A Pilot Study (Q58563482) (← links)
- Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients (Q59845387) (← links)
- Age-Associated Changes in the Immune System and Blood⁻Brain Barrier Functions (Q64085536) (← links)